CYCLORPHAN

[H][C@@]12CCCC[C@@]13CCN(CC4CC4)[C@@H]2CC5=CC=C(O)C=C35

InChIKey=NLBUEDSBXVNAPB-DFQSSKMNSA-N

InChI=1S/C20H27NO/c22-16-7-6-15-11-19-17-3-1-2-8-20(17,18(15)12-16)9-10-21(19)13-14-4-5-14/h6-7,12,14,17,19,22H,1-5,8-11,13H2/t17-,19+,20+/m0/s1

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	3 / 3
E/Z Centers	0
Optical Activity	UNSPECIFIED

PubMed

Title	Date	PubMed
In vivo characterization of (-)(-)MCL-144 and (+)(-)MCL-193: isomeric, bivalent ligands with mu/kappa agonist properties.	2008 Oct	18528756
Synthesis and opioid receptor binding affinities of 2-substituted and 3-aminomorphinans: ligands for mu, kappa, and delta opioid receptors.	2010 Jan 14	19928862

Patents

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:32:09 GMT 2023` Edited by `admin` on `Fri Dec 15 15:32:09 GMT 2023`
Record UNII	U6Z73N36V0
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

CYCLORPHAN

Common Name

English

MORPHINAN-3-OL, 17-(CYCLOPROPYLMETHYL)-

Systematic Name

English

CYCLORPHAN [MI]

Common Name

English

17-(CYCLOPROPYLMETHYL)MORPHINAN-3-OL

Systematic Name

English

(-)-CYCLORPHAN

Common Name

English

MORPHINAN, N-(CYCLOPROPYLMETHYL)-3-HYDROXY-

Systematic Name

English

Code System Code Type Description

ECHA (EC/EINECS)

224-007-5